23474-66-0

Usage

Uses

Used in Pharmaceutical Industry:
2-AMINO-10H-DIBENZO[B,F][1,4]OXAZEPIN-11-ONE is used as an active pharmaceutical ingredient for the development of antidepressant medications. Its application is based on its ability to exhibit antidepressant activity, which can be beneficial for individuals suffering from various forms of depression.
The compound's antidepressant properties make it a promising candidate for the development of new treatments for depression, potentially offering alternative options to existing medications and addressing the needs of patients who do not respond well to current therapies.

Upstream product

• 16398-07-5 2-chloro-N-(2-hydroxyphenyl)-5-nitrobenzamide 
• 95-55-6 2-amino-phenol 
• 2516-96-3 2-chloro-5-nitrobenzoic acid 
• 16398-16-6 2-nitro-10H-dibenzo1,4-oxazepin-11-one 

Downstream Products

• 3158-85-8 10H-dibenzo[b,f][1,4]oxazepin-11-one 

Relevant academic research and scientific papers

TRICYCLIC COMPOUNDS WITH OMA1/OPA1 MODULATORY PROPERTIES

Tricyclic compounds, and in particular novel dibenzoxazepin derivates are disclosed herein, which were quite surprisingly found as having OMA1 and/or OPA1 modulatory properties. Compounds of present invention may provide useful for the treatment of certai

N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations

New N-hydroxyamides of n-alkyl carboxylic acids omega substituted with suitable tricyclic systems characterised by a central 7-membered ring, having activity as inhibitors of histone deacetylase (HDAC).

N-HYDROXYAMIDES OMEGA-SUBSTITUTED WITH TRICYCLIC GROUPS AS HISTONE DEACETYLASE INHIBITORS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS

New N-hydroxyamides of n-alkyl carboxylic acids omega substituted with suitable tricyclic systems characterised by a central 7-membered ring, having activity as inhibitors of histone deacetylase (HDAC).

Tricyclic compounds with NOS activity

The present invention provides novel tricyclic compounds, compositions comprising these compounds and methods of using these compounds as neuroprotectants. In particular, the compounds of the invention are useful for treating stroke.